DE2008493C3 - Hämatologische Kontrollflüssigkeit - Google Patents

Hämatologische Kontrollflüssigkeit

Info

Publication number: DE2008493C3
Authority: DE; Germany
Prior art keywords: blood cells; control fluid; red blood; solution; human
Prior art date: 1969-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

DE2008493A

Other languages

German (de)

English (en)

Other versions

DE2008493A1 (de

DE2008493B2 (de

Inventor

Anthony Elmhurst N.Y. Decasperis (V.St.A.)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1969-02-25

Filing date

1970-02-24

Publication date

1979-09-27

1970-02-24 Application filed by Pfizer Inc filed Critical Pfizer Inc

1970-09-03 Publication of DE2008493A1 publication Critical patent/DE2008493A1/de

1979-01-25 Publication of DE2008493B2 publication Critical patent/DE2008493B2/de

1979-09-27 Application granted granted Critical

1979-09-27 Publication of DE2008493C3 publication Critical patent/DE2008493C3/de

Status Expired legal-status Critical Current

Links

230000002489 hematologic effect Effects 0.000 title claims description 20
239000012530 fluid Substances 0.000 title claims description 17
210000003743 erythrocyte Anatomy 0.000 claims description 37
239000000725 suspension Substances 0.000 claims description 17
210000004027 cell Anatomy 0.000 claims description 13
210000000601 blood cell Anatomy 0.000 claims description 12
239000003146 anticoagulant agent Substances 0.000 claims description 6
229940127219 anticoagulant drug Drugs 0.000 claims description 6
244000144977 poultry Species 0.000 claims description 6
IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 claims description 4
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 4
229930024421 Adenine Natural products 0.000 claims description 4
230000002378 acidificating effect Effects 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 2
239000013543 active substance Substances 0.000 claims 1
RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 claims 1
239000000243 solution Substances 0.000 description 30
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
210000000265 leukocyte Anatomy 0.000 description 18
210000004369 blood Anatomy 0.000 description 17
239000008280 blood Substances 0.000 description 17
102000001554 Hemoglobins Human genes 0.000 description 10
108010054147 Hemoglobins Proteins 0.000 description 10
239000000203 mixture Substances 0.000 description 8
238000000034 method Methods 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
238000005534 hematocrit Methods 0.000 description 5
239000007788 liquid Substances 0.000 description 5
239000000047 product Substances 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
235000018553 tannin Nutrition 0.000 description 5
229920001864 tannin Polymers 0.000 description 5
239000001648 tannin Substances 0.000 description 5
239000006285 cell suspension Substances 0.000 description 4
235000013594 poultry meat Nutrition 0.000 description 4
239000003755 preservative agent Substances 0.000 description 4
239000013643 reference control Substances 0.000 description 4
239000000872 buffer Substances 0.000 description 3
239000007975 buffered saline Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
241000272517 Anseriformes Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
108090000190 Thrombin Proteins 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
239000012266 salt solution Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
229960004072 thrombin Drugs 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
SOHAVULMGIITDH-ZXPSTKSJSA-N (1S,9R,14E)-14-(1H-imidazol-5-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione Chemical compound C([C@]1(C2=CC=CC=C2N([C@@]21NC1=O)OC)C(C)(C)C=C)=C(OC)C(=O)N2\C1=C\C1=CNC=N1 SOHAVULMGIITDH-ZXPSTKSJSA-N 0.000 description 1
MKPCNMXYTMQZBE-UHFFFAOYSA-N 7h-purin-6-amine;sulfuric acid;dihydrate Chemical compound O.O.OS(O)(=O)=O.NC1=NC=NC2=C1NC=N2.NC1=NC=NC2=C1NC=N2 MKPCNMXYTMQZBE-UHFFFAOYSA-N 0.000 description 1
241000271566 Aves Species 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
241000031711 Cytophagaceae Species 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
SOHAVULMGIITDH-UHFFFAOYSA-N Oxaline Natural products O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)C=C(OC)C(=O)N2C1=CC1=CN=CN1 SOHAVULMGIITDH-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
230000005786 degenerative changes Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
235000019800 disodium phosphate Nutrition 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
210000002064 heart cell Anatomy 0.000 description 1
229910052595 hematite Inorganic materials 0.000 description 1
239000011019 hematite Substances 0.000 description 1
LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229910052762 osmium Inorganic materials 0.000 description 1
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000011148 porous material Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE2008493A 1969-02-25 1970-02-24 Hämatologische Kontrollflüssigkeit Expired DE2008493C3 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US80226369A	1969-02-25	1969-02-25

Publications (3)

Publication Number	Publication Date
DE2008493A1 DE2008493A1 (de)	1970-09-03
DE2008493B2 DE2008493B2 (de)	1979-01-25
DE2008493C3 true DE2008493C3 (de)	1979-09-27

Family

ID=25183239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE2008493A Expired DE2008493C3 (de)	1969-02-25	1970-02-24	Hämatologische Kontrollflüssigkeit

Country Status (6)

Country	Link
US (1)	US3574137A (es)
DE (1)	DE2008493C3 (es)
ES (1)	ES376863A1 (es)
FR (1)	FR2035733A5 (es)
GB (1)	GB1215662A (es)
SE (1)	SE376485B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0342398A1 (de) *	1988-05-14	1989-11-23	Dimitrios Dr. Giannitsis	Verfahren zum Nachweis von Antikörpern gegen erythrozytenspezifische Antigene

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3873467A (en) *	1974-02-01	1975-03-25	United Medical Lab Inc	Hematologic reference control
US3977995A (en) *	1974-10-17	1976-08-31	Baxter Laboratories, Inc.	Calibrating fluid for blood cell counting and hemoglobin determination
JPS5247012B2 (es) *	1974-11-16	1977-11-29
US3962125A (en) *	1975-01-13	1976-06-08	Coulter Diagnostics, Inc.	Multi-purpose diluent for use in blood analysis by electronic instrumentation of the coulter type
US4020006A (en) *	1975-08-14	1977-04-26	Icl/Scientific	Fluid containing dispersed particles simulating leukocytes and method for producing same
US3973913A (en) *	1976-01-29	1976-08-10	Louderback Allan Lee	Blood control standard
US4179398A (en) *	1977-03-21	1979-12-18	ICN Medical Laboratories, Inc.	Platelet control composition
US4160644A (en) *	1977-06-13	1979-07-10	Streck Laboratories, Inc.	Platelet reference control and method of preparation
US4198206A (en) *	1977-06-13	1980-04-15	Ryan Wayne L	Method for preparing a platelet reference control
DE2745151C2 (de) *	1977-10-07	1984-06-20	Walter Sarstedt Kunststoff-Spritzgußwerk, 5223 Nümbrecht	Mittel zur Erleichterung der Auszählung von Thrombozyten in Blutproben
US4282326A (en) *	1978-10-12	1981-08-04	Jeanne Moldenhauer	Cell culture medium supplement
US4250051A (en) *	1978-12-26	1981-02-10	Coulter Electronics, Inc.	Preservative for use in calibrator compositions for blood analysis
US4299726A (en) *	1979-05-07	1981-11-10	Coulter Electronics, Inc.	Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor
US4358394A (en) *	1979-05-07	1982-11-09	Coulter Electronics, Inc.	Process for preparing whole blood reference controls having long term stability
US4579824A (en) *	1983-05-18	1986-04-01	Louderback Allan Lee	Hematology control
US4704364A (en) *	1984-05-18	1987-11-03	Coulter Electronics, Inc.	Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
US5039487A (en) *	1987-12-22	1991-08-13	Board Of Regents, The University Of Texas System	Methods for quantifying components in liquid samples
US5270208A (en) *	1991-05-09	1993-12-14	Streck Laboratories, Inc.	White blood cell hematology control
US6509192B1 (en) *	1992-02-24	2003-01-21	Coulter International Corp.	Quality control method
US6362003B1 (en) *	1992-02-24	2002-03-26	Coulter Corporation	Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
US5994139A (en) *	1998-04-07	1999-11-30	Coulter International Corp.	Stable hematology control composition and method of use
US6200500B1 (en)	1999-08-20	2001-03-13	Streck Laboratories, Inc.	Hematology control and system for multi-parameter hematology measurements
US6221668B1 (en)	1999-08-20	2001-04-24	Streck Laboratories, Inc.	Hematology control and system for multi-parameter hematology measurements
US6653137B2 (en)	2001-12-03	2003-11-25	Streck Laboratories Inc.	Hematology reference control
US6723563B2 (en)	2001-12-03	2004-04-20	Streck Laboratories Inc.	Hematology reference control

1969
- 1969-02-25 US US802263A patent/US3574137A/en not_active Expired - Lifetime
- 1969-05-02 GB GB22646/69A patent/GB1215662A/en not_active Expired
1970
- 1970-02-23 SE SE7002307A patent/SE376485B/xx unknown
- 1970-02-24 ES ES376863A patent/ES376863A1/es not_active Expired
- 1970-02-24 DE DE2008493A patent/DE2008493C3/de not_active Expired
- 1970-02-25 FR FR7006740A patent/FR2035733A5/fr not_active Expired

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0342398A1 (de) *	1988-05-14	1989-11-23	Dimitrios Dr. Giannitsis	Verfahren zum Nachweis von Antikörpern gegen erythrozytenspezifische Antigene

Also Published As

Publication number	Publication date
GB1215662A (en)	1970-12-16
US3574137A (en)	1971-04-06
ES376863A1 (es)	1972-05-01
DE2008493A1 (de)	1970-09-03
DE2008493B2 (de)	1979-01-25
FR2035733A5 (es)	1970-12-18
SE376485B (es)	1975-05-26

Publication	Publication Date	Title
DE2008493C3 (de)	1979-09-27	Hämatologische Kontrollflüssigkeit
DE1698180C3 (de)	1979-01-25	Verfahren zur Herstellung eines Blutserum-Bezugsnormals
DE3586619T2 (de)	1993-04-22	Haematologische zusammensetzungen als referenz fuer drei populationen von leukocyten, verfahren zu deren herstellung und deren verwendung in ganzbluttestverfahren.
DE3017152C2 (es)	1990-02-15
US3640896A (en)	1972-02-08	Process for stabilizing fowl red blood cells
DE69716064T2 (de)	2004-01-08	Flüssigkeit zum sammeln von proben
DE68912115T2 (de)	1994-08-11	Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.
DE2602997C2 (de)	1983-05-11	Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung
CH641046A5 (de)	1984-02-15	Verfahren zur herstellung bestaendiger urokinasemittel.
DD202178A5 (de)	1983-08-31	Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen
DE2628468C2 (de)	1982-05-06	Verfahren zur Färbung von Basophilen und Reagens zur Durchführung dieses Verfahrens
EP0145005B1 (de)	1989-04-12	Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE2850950C3 (de)	1981-11-19	Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
EP0141922A1 (de)	1985-05-22	Verfahren zur Verringerung einer Trübung in Kontrollseren
DE3311458C2 (de)	1986-02-13	Verfahren zur Herstellung einer glukosefreien Hämoglobinkontrolle
EP1242825B1 (de)	2005-03-09	Gewinnung von lipoproteinen aus körperflüssigkeiten
DE2314263C2 (de)	1982-11-25	Synthetischer Kontrollstandard zur Analyse der cerebrospinalen Flüssigkeit und seine Herstellung
DE69804216T2 (de)	2002-11-07	Verhinderung der koagulation von blut-, blutplasma- bzw. synovialflüssigkeitsprodukten
DE2715748B2 (de)	1981-03-19	Gereinigte aktive Verbindung des Plasminogen-Typs menschlichen Ursprungs und ihre Verwendung
DE2748520C2 (es)	1987-07-30
DE3873984T2 (de)	1993-02-04	Loesung zur kontrolle der taetigkeit einer chromatographischen ionenaustauschersaeule eines hplc-apparates und methode zu ihrer herstellung.
DE1247704B (de)	1967-08-17	Verfahren zur Herstellung einer hoch Chloesterin haltigen Kontroll-Standard-Loesung fuer die Bestimmung des Blutcholesterinspiegels
EP0294714B1 (de)	1992-07-22	Verwendung von Polyvinylpyrrolidon (PVP) zur Trübungsminderung von Seren, Seren enthaltend PVP und Verfahren zu deren Herstellung
DE2857710A1 (de)	1981-04-16	Bestimmung von ldl-cholesterin in koerperfluiden
DE69327498T2 (de)	2000-06-08	Antithrombin III - Präparation

Legal Events

Date	Code	Title	Description
1979-09-27	C3	Grant after two publication steps (3rd publication)
1987-03-19	8339	Ceased/non-payment of the annual fee

DE2008493C3 - Hämatologische Kontrollflüssigkeit - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (3)

Family

ID=25183239

Family Applications (1)

Country Status (6)

Cited By (1)

Families Citing this family (25)

Cited By (1)

Also Published As

Similar Documents

Legal Events